Compare ALEMBIC LTD with Fresenius Kabi Onco. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs FRESENIUS KABI ONCO. - Comparison Results

ALEMBIC LTD     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD FRESENIUS KABI ONCO. ALEMBIC LTD/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 52.4 22.1 236.9% View Chart
P/BV x 4.5 3.1 145.1% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 ALEMBIC LTD   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
FRESENIUS KABI ONCO.
Mar-13
ALEMBIC LTD/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs72176 40.9%   
Low Rs3479 43.2%   
Sales per share (Unadj.) Rs4.737.7 12.5%  
Earnings per share (Unadj.) Rs6.15.1 119.8%  
Cash flow per share (Unadj.) Rs6.26.7 92.9%  
Dividends per share (Unadj.) Rs0.200-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs40.742.5 95.6%  
Shares outstanding (eoy) m267.03158.23 168.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.33.4 333.6%   
Avg P/E ratio x8.725.0 34.7%  
P/CF ratio (eoy) x8.518.9 44.8%  
Price / Book Value ratio x1.33.0 43.5%  
Dividend payout %3.30-   
Avg Mkt Cap Rs m14,13920,135 70.2%   
No. of employees `000NA1.2 0.0%   
Total wages/salary Rs m207703 29.5%   
Avg. sales/employee Rs ThNM5,176.2-  
Avg. wages/employee Rs ThNM610.4-  
Avg. net profit/employee Rs ThNM699.6-  
INCOME DATA
Net Sales Rs m1,2555,963 21.0%  
Other income Rs m37018 2,056.7%   
Total revenues Rs m1,6255,981 27.2%   
Gross profit Rs m1111,430 7.8%  
Depreciation Rs m38258 14.7%   
Interest Rs m2-26 -6.5%   
Profit before tax Rs m4421,216 36.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m24342 7.0%   
Profit after tax Rs m1,630806 202.2%  
Gross profit margin %8.924.0 36.9%  
Effective tax rate %5.428.1 19.3%   
Net profit margin %129.813.5 960.8%  
BALANCE SHEET DATA
Current assets Rs m1,8675,102 36.6%   
Current liabilities Rs m5912,385 24.8%   
Net working cap to sales %101.645.6 223.2%  
Current ratio x3.22.1 147.7%  
Inventory Days Days94150 62.8%  
Debtors Days Days74113 64.9%  
Net fixed assets Rs m1,7915,148 34.8%   
Share capital Rs m534158 337.6%   
"Free" reserves Rs m10,3246,556 157.5%   
Net worth Rs m10,8586,732 161.3%   
Long term debt Rs m41952 4.3%   
Total assets Rs m11,59110,388 111.6%  
Interest coverage x260.9-45.8 -569.9%   
Debt to equity ratio x00.1 2.7%  
Sales to assets ratio x0.10.6 18.9%   
Return on assets %14.17.5 187.5%  
Return on equity %15.012.0 125.4%  
Return on capital %15.214.6 104.0%  
Exports to sales %1.574.5 2.1%   
Imports to sales %21.024.8 84.7%   
Exports (fob) Rs m194,441 0.4%   
Imports (cif) Rs m2631,477 17.8%   
Fx inflow Rs m195,298 0.4%   
Fx outflow Rs m2641,772 14.9%   
Net fx Rs m-2443,525 -6.9%   
CASH FLOW
From Operations Rs m2361,274 18.5%  
From Investments Rs m-224-1,204 18.6%  
From Financial Activity Rs m-27-196 13.6%  
Net Cashflow Rs m-15-126 11.7%  

Share Holding

Indian Promoters % 64.0 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 0.2 0.3 66.7%  
FIIs % 9.7 9.6 101.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 9.1 286.8%  
Shareholders   54,701 42,599 128.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   SUN PHARMA  DR. REDDYS LAB  GSK PHARMA  FULFORD INDIA  PROCTER & GAMBLE HEALTH  

Compare ALEMBIC LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 748 Points Higher; Energy and Finance Stocks Rally(Closing)

Indian share markets continued their momentum and ended on a strong note today. The three-day Monetary Policy Committee meeting kicked off today.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY19); Net Profit Up 106.9% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, ALEMBIC LTD has posted a net profit of Rs 69 m (up 106.9% YoY). Sales on the other hand came in at Rs 445 m (up 50.4% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Why the Stock of HDFC Bank Deserves a Closer Look than Before...(Profit Hunter)

Jul 22, 2020

HDFC Bank's results point to a gaping hole in Indian financial sector. Possibly even a global contagion.

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio(Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

My Best Trading Ideas When Interest Rates Are So Low(Fast Profits Daily)

Jul 23, 2020

India's interest rates are lower than the inflation rate. Here are the best trades for this situation.

Gold or Silver: Which One Should You Buy Now?(Fast Profits Daily)

Jul 24, 2020

Silver and gold are both vying for your attention. Which is the better trade today?

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 4, 2020 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - ALKEM LABORATORIES COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS